NDC11 41167041302
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 41167-0413-02 | 41167-0413 |
| 41167-0413-2 | 41167-0413 |
| 41167-413-02 | 41167-413 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gold Bond Psoriasis Relief Medicated Multi-Symptom | SALICYLIC ACID | Chattem, Inc. | e8479bbc-5f49-41f2-851e-a93543516639 | 2025-03-19 | Warnings | 41167-0413-2 41167-0413 41167041302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.